LENZ Therapeutics Inc (LENZ) USD0.001

Sell:$31.82Buy:$32.01$0.31 (0.98%)

NASDAQ:0.05%
Market closed | Prices delayed by at least 15 minutes
Sell:$31.82
Buy:$32.01
Change:$0.31 (0.98%)
Market closed | Prices delayed by at least 15 minutes
Sell:$31.82
Buy:$32.01
Change:$0.31 (0.98%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 May 2024
Daniel R. (Dan) ChevallardCFO
Buy
Regular purchase transaction
3,188$15.68$49,987.843,188
13 May 2024
James W (Jim) McCollumDirector
Buy
Regular purchase transaction
31,332$15.99$501,092.68525,565
21 March 2024
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
933,038$15.03$14,023,561.143,319,339
21 March 2024
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
64,971$15.03$976,514.13694,755
21 March 2024
James W (Jim) McCollumDirector
Buy
Regular purchase transaction
16,633$15.03$249,992.33494,233

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
21 March 2024
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
933,038$15.03$14,023,561.143,319,339
21 March 2024
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
64,971$15.03$976,514.13694,755
13 May 2024
James W (Jim) McCollumDirector
Buy
Regular purchase transaction
31,332$15.99$501,092.68525,565
21 March 2024
James W (Jim) McCollumDirector
Buy
Regular purchase transaction
16,633$15.03$249,992.33494,233
14 May 2024
Daniel R. (Dan) ChevallardCFO
Buy
Regular purchase transaction
3,188$15.68$49,987.843,188

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.